Correlation of ACR TI-RADS ultrasound classification with cytopathology: a retrospective evaluation of diagnostic accuracy

Year 2026, Volume: 9 Issue: 2 , 360 - 364 , 12.03.2026

Şeref Barbaros Arık , Pınar Atabey

https://doi.org/10.32322/jhsm.1853967

https://izlik.org/JA77ZN95KL

Abstract

Aims: To evaluate the diagnostic performance of the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) in predicting malignancy in thyroid nodules and to assess the correlation between TI-RADS categories, cytopathological outcomes, and guideline-recommended biopsy thresholds.
Methods: This retrospective single-center study included 567 thyroid nodules evaluated with ultrasound and Doppler imaging between January 2023 and November 2025. TI-RADS scores were retrospectively assigned according to ACR criteria based on sonographic features. Cytopathology served as the reference standard, with nodules classified as benign (Bethesda II) or malignant/suspicious for malignancy (Bethesda V–VI). Diagnostic performance metrics of TI-RADS ≥4 were calculated, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and area under the receiver operating characteristic curve (AUC). Multivariate logistic regression was performed to identify independent predictors of malignancy.
Results: Of the 567 nodules, 33 (5.8%) were malignant. Malignancy rates increased across TI-RADS categories, reaching 31.6% in TR5 nodules. Using TI-RADS ≥4 as the threshold, sensitivity was 78.8%, specificity 61.0%, PPV 11.1%, and NPV 97.9%, with an overall accuracy of 62.1% and an AUC of 0.75 (p<0.001). Multivariate analysis demonstrated that both TI-RADS score (OR=4.09 per category increase, p<0.001) and nodule size (OR=1.04 per mm, p=0.013) were independent predictors of malignancy. Nodules meeting guideline-based biopsy size criteria showed significantly higher malignancy odds.
Conclusion: ACR TI-RADS provides reliable malignancy risk stratification with a high NPV in routine clinical practice. The system effectively reduces unnecessary biopsies while maintaining diagnostic safety, supporting its continued use as a standardized ultrasound-based risk stratification tool for thyroid nodules.

Keywords

ACR TI-RADS , thyroid nodule , ultrasonography , cytopathology , diagnostic accuracy , risk stratification

Ethical Statement

Ethical approval for this study was obtained from the Yüksek İhtisas University Health Sciences Research Ethics Committee (approval date: 24.12.2025; decision no: 375)

Supporting Institution

This study received no financial support.

Thanks

No technical assistance was obtained from third parties or institutions for translation, statistical analysis, data collection, or editorial evaluation. Therefore, there is no acknowledgment to declare.

References

• Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. doi:10.1089/thy.2015.0020
• Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375(7):614-617. doi:10.1056/NEJMp 1604412
• Seo H, Na DG, Kim JH, Kim KW, Yoon JW. Ultrasound-based risk stratification for malignancy in thyroid nodules: a four-tier categorization system. Eur Radiol. 2015;25(7):2153-2162. doi:10.1007/s00330-015-3621-7
• Na DG, Baek JH, Sung JY, et al. Thyroid imaging reporting and data system risk stratification of thyroid nodules: categorization based on solidity and echogenicity. Thyroid. 2016;26(4):562-572. doi:10.1089/thy. 2015.0460
• Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017;14(5):587-595. doi:10.1016/j.jacr.2017.01.046
• Chen Q, Lin M, Wu S. Validating and comparing C-TIRADS, K-TIRADS and ACR-TIRADS in stratifying the malignancy risk of thyroid nodules. Front Endocrinol (Lausanne). 2022;13:899575. doi:10.3389/fendo.2022.899575
• Hoang JK, Langer JE, Middleton WD, et al. Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee. J Am Coll Radiol. 2015;12(2):143-150. doi: 10.1016/j.jacr.2014.09.038
• Park JY, Lee HJ, Jang HW, et al. A proposal for a thyroid imaging reporting and data system for ultrasound features of thyroid carcinoma. Thyroid. 2009;19(11):1257-1264. doi:10.1089/thy.2008.0021
• Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892-899. doi:10.1148/radiol.11110206
• Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer. Thyroid. 2025;35(8):841-985. doi:10.1177/10507256251363120
• Tessler FN, Middleton WD, Grant EG. Thyroid Imaging Reporting and Data System (TI-RADS): a user's guide. Radiology. 2018;287(1):29-36. doi:10.1148/radiol.2017171240
• Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus conference statement. Radiology. 2005;237(3):794-800. doi:10.1148/radiol.2373050220